New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 14, 2017 – The FDA approved Nesher Pharmaceuticals’ AB-rated generic version of Genetech’s Tamiflu (oseltamivir phosphate) oral suspension.
Download PDF
Return to publications
